PATENT CLAIM ANALYSIS

Application Number: 16269243
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "252160"]

Abstract:
Disclosed herein are methods for increasing the overall vigor of a subject, and/or vigor of target tissues of a subject. Exemplified herein is the utilization of pyrimidine derivatives which act to stimulate stem cell proliferation. In addition to increasing vigor, such stem cell proliferation agents (SCPA) may be used to enhance and/or improve the outcome of other therapies, and may be used in psychiatric applications. Increasing vigor in subjects is not necessarily targeted to the treatment of a disease, thus, the methods can include administration to clinically healthy animals.

Claim (Index 1):
A method of improving skin tone of a subject's skin comprising topically administering to non-wounded skin of said subject a therapeutically effective amount of a composition comprising 2-Piperadino-6-methyl-5-oxo-5,6-dihydro(7H)pyrro-[3,4-d]pyrimidine, or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.6129
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13061159', '14417250', '12219198', '14913549', '14019442']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7106223193240141
- 35 USC 102 Novelty (BERT): 0.4643282345981847
- Combined Prediction Score: 0.6859929108514312
- Mean Citation Score: 102.6157248
- Max Citation Score: 146.26706
- Similarity Product: 111.88962585449455

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test